These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15860370)

  • 21. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies.
    Cohen-Zion M; Ancoli-Israel S
    Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy.
    Mohammadi M; Akhondzadeh S
    Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attention-deficit/hyperactivity disorder and sleep disorders in children.
    Tsai MH; Huang YS
    Med Clin North Am; 2010 May; 94(3):615-32. PubMed ID: 20451036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of stimulants on height and weight: a review of the literature.
    Faraone SV; Biederman J; Morley CP; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stimulant therapy of hyperkinetic syndrome in childhood and adolescence].
    Schulz E; Remschmidt H
    Z Kinder Jugendpsychiatr; 1990 Sep; 18(3):157-66. PubMed ID: 1981119
    [No Abstract]   [Full Text] [Related]  

  • 26. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.
    Denney CB
    J Clin Child Psychol; 2001 Mar; 30(1):98-109. PubMed ID: 11294083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy of attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attention-deficit/hyperactivity disorder.
    Shaywitz BA; Fletcher JM; Shaywitz SE
    Adv Pediatr; 1997; 44():331-67. PubMed ID: 9265975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of short-acting methylphenidate on growth rates of children with attention deficit hyperactivity disorder at Queen Sirikit National Institute of Child Health.
    Moungnoi P; Maipang P
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S158-63. PubMed ID: 22043770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children.
    Kociancic T; Reed MD; Findling RL
    Expert Opin Drug Saf; 2004 Mar; 3(2):93-100. PubMed ID: 15006715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
    J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition and treatment of attention deficit disorder.
    Bond WS
    Clin Pharm; 1987 Aug; 6(8):617-24. PubMed ID: 2891464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altering the course of neurodevelopment: a framework for understanding the enduring effects of psychotropic drugs.
    Andersen SL; Navalta CP
    Int J Dev Neurosci; 2004; 22(5-6):423-40. PubMed ID: 15380841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Annual Research Review: New frontiers in developmental neuropharmacology: can long-term therapeutic effects of drugs be optimized through carefully timed early intervention?
    Andersen SL; Navalta CP
    J Child Psychol Psychiatry; 2011 Apr; 52(4):476-503. PubMed ID: 21309771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postnatal brain development and psychotropic drugs. Effects on animals and animal models of depression and attention-deficit/hyperactivity disorder.
    Bock N; Gerlach M; Rothenberger A
    Curr Pharm Des; 2010; 16(22):2474-83. PubMed ID: 20513226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of toxins on the developing brain.
    Lanphear BP
    Annu Rev Public Health; 2015 Mar; 36():211-30. PubMed ID: 25581143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.